Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer

Mary Ellen Taplin, Meredith M. Regan, Yoo Joung Ko, Glenn J. Bubley, Stephen E. Duggan, Lillian Werner, Tomasz M. Beer, Christopher W. Ryan, Paul Mathew, Shi Ming Tu, Samuel R. Denmeade, William K. Oh, Oliver Sartor, Christos S. Mantzoros, Roger Rittmaster, Philip W. Kantoff, Steven P. Balk

    Research output: Contribution to journalArticlepeer-review

    66 Scopus citations

    Fingerprint Dive into the research topics of 'Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer'. Together they form a unique fingerprint.

    Medicine & Life Sciences